宫内脊髓脊膜膨出修复术后泌尿系统结局的前100例前瞻性分析
该前瞻性分析评估了前100例宫内脊髓脊膜膨出修复术后患儿的泌尿系统结局,旨在明确膀胱功能是否改善。结果显示仅14.7%患儿膀胱功能正常,52.6%为高风险膀胱,27.4%为尿失禁,4.2%为膀胱活动低下。结论提示宫内修复对泌尿系统获益有限。
要点
- 宫内脊髓脊膜膨出修复后仅14.7%患儿膀胱功能正常
- 52.6%患儿为高风险膀胱,需密切监测和干预
- 57.3%患儿需清洁间歇导尿,52.6%需抗胆碱能药物
核心结论
- 膀胱功能异常发生率高,提示宫内脊髓脊膜膨出修复对泌尿系统获益有限。
研究设计与样本
- 前瞻性分析,纳入前100例宫内脊髓脊膜膨出修复术后患儿,平均年龄5.8个月(中位4个月)。
- 方案包括详细病史、泌尿系超声、排尿性膀胱尿道造影和尿动力学评估。
- 患儿分为正常、高风险(逼尿肌漏尿点压>40 cm H2O且充盈压>40 cm H2O的膀胱过度活动)、尿失禁和膀胱活动低下(伴排尿后残余尿)四组。
主要发现
- 高风险膀胱占52.6%,尿失禁占27.4%,膀胱活动低下占4.2%,正常膀胱仅占14.7%。
- 57.3%患儿启动清洁间歇导尿,52.6%使用抗胆碱能药物。
- 19.1%存在膀胱输尿管反流的患儿启动抗生素预防。
关键数值与推荐
- 高风险膀胱定义:膀胱过度活动且逼尿肌漏尿点压>40 cm H2O、充盈压>40 cm H2O。
- 膀胱活动低下定义:膀胱活动低下伴排尿后残余尿。
临床怎么用
- 宫内修复术后应常规行尿动力学评估以早期识别高风险膀胱。
- 根据分组启动清洁间歇导尿、抗胆碱能药物或抗生素预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the first 100 cases of in utero myelomeningocoele (MMC) repair and urological outcomes in a prospective analysis aiming to define possible improvement in bladder function. PATIENTS AND METHODS: We used a protocol consisting of a detailed medical history, urinary tract ultrasonography, voiding cystourethrography, and urodynamic evaluation. Patients were categorised into four groups: normal, high risk (overactive bladder with a detrusor leak-point pressure >40 cm H2 O and high filling pressures also >40 cm H2 O), incontinent, and underactivity (underactive bladder with post-void residual urine), and patients were treated accordingly. RESULTS: We evaluated 100 patients, at a mean age of 5.8 months (median 4 months), classified as high risk in 52.6%, incontinent in 27.4%, with underactive bladder in 4.2%, and only 14.7% had a normal bladder profile. Clean intermittent catheterisation was initiated in 57.3% of the patients and anticholinergics in 52.6%. Antibiotic prophylaxis was initiated in 19.1% of the patients presenting with vesico-ureteric reflux. CONCLUSION: The high incidence of abnormal bladder patterns suggests little benefit of in utero MMC surgery concerning the urinary tract.
引用
- Macedo A, Ottoni SL, Garrone G, et al. In utero myelomeningocoele repair and urological outcomes: the first 100 cases of a prospective analysis. Is there an improvement in bladder function? BJU Int. 2019. PMID: 30548158. doi:10.1111/bju.14639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。